Auth bypass in Quanovate Tech Inc. (Operating As Mira / Care) Android App

CVE-2026-66875

In the Mira hormone monitor device firmware v1.7.1.47 build 01070147, a remote unauthenticated attacker within BLE range (approximately 10–30 meters) can silently rebind the device to an attacker-controlled account, extract stored hormone measurements in cleartext, cause a denial-of-service via malformed or undocumented command opcodes, and passively track the user via a static random BLE address that never rotates.

Vulnerability class: Broken Authentication

Published · last modified .

CVSS v3 metric

CVSS v3 base score 8.8 (High). Vector: CVSS:3.1/AV:A/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H.

EPSS exploit prediction

EPSS: 0.004 (32.1th percentile), scored .

Very low probability of exploitation in the next 30 days; routine patching cadence is appropriate. 32nd percentile — 32.1% of CVEs in the catalogue have a lower EPSS than this one. How to read EPSS.

EPSS trend (30 days)EPSS over the last 30 days for CVE-2026-66875: held from 0.003 to 0.004.

EPSS over last 30 days · oldest: 0.003 · newest: 0.004 · change: +0.001

Affected products

Weakness classification (CWE)

References

Frequently asked questions

What is CVE-2026-66875?
CVE-2026-66875 is a high-severity vulnerability in Quanovate Tech Inc. (Operating As Mira / Care) Android App, classified under Missing Authentication for Critical Function. CVSS score: 8.8/10. Published 2026-08-11.
How severe is CVE-2026-66875?
High severity. CVSS v3 base score is 8.8 out of 10.